Mauritius-based entity sells Rs 289 crore value shares in Emcure Prescription drugs through block deal; Norges Financial institution acquirer
The shares had been bought by Norges Financial institution on Account of The Authorities Pension Fund World at a value of Rs 1,608.2 apiece. The inventory at the moment ended with robust positive factors of 8% at Rs 1,729.90 on the NSE.
BC Investments IV, an affiliate of Bain Capital, held over 73.39 lakh shares accounting for 3.87% stake within the firm as on March 31, 2026.
The inventory has delivered returns of 67% prior to now 12 months, outperforming the benchmarks Nifty and the BSE Sensex, whose returns in the identical interval stand at -1% and -3%, respectively.
The inventory is at present buying and selling above its 50-day and 200-day easy transferring averages (SMAs) of Rs 1,535 and Rs 1,438, respectively, based on Trendlyne information.
The pharma firm is into manufacturing APIs and formulations.
The corporate reported a consolidated web revenue of Rs 231 crore which is a development of fifty% over Rs 154 crore reported within the yr in the past interval. The corporate reported a complete income of Rs 2,365 crore which is development of 20% YoY versus Rs 1,966 crore within the corresponding quarter of the final monetary yr.Emcure Prescription drugs is a smallcap inventory with a market capitalization of Rs 32,742 crore.
Additionally learn: Delhivery block offers value Rs 186 crore see Goldman Sachs, Morgan Stanley, MFs step in; Nexus sells stake
(Disclaimer: The suggestions, ideas, views, and opinions given by the consultants are their very own. These don’t symbolize the views of The Financial Occasions.)
